March 18, 2008
A cancer treatment technology developed by Duke materials engineer David Needham and radiation oncologist Mark Dewhirst has started Phase III human clinical trials in both Hong Kong and the United States. The technology is a heat-sensitive engineered capsule called a liposome containing the [...]
March 17, 2008
Bioptigen, a spinoff company co-founded by Duke biomedical engineer Joseph Izatt, has won the Frost & Sullivan 2007 North American Optical Coherence Tomography Excellence in Research Award. Bioptigen was singled out for its work in spectral-domain optical coherence tomography (SD-OCT) for [...]
March 14, 2006
For most doctoral students, the path forward is clear: industry research career or academic research and teaching career. But Audrey Ellerbee, originally from New York, is considering a different path. And that’s not at all unusual for her.